Dec 09 FDA expands Pfizer COVID booster, opens extra dose to age 16 By Lauren Neergaard and Matthew Perrone, Associated Press The U.S. and many other nations already urge adults to get a booster to pump up their immunity months after initial vaccination. Continue reading
Nov 30 FDA panel review final hurdle for Merck’s COVID-19 pill By Matthew Perrone, Associated Press U.S. health advisers are reviewing Merck's closely watched COVID-19 pill, which could become the first easy-to-use drug for American patients. Continue reading
Nov 16 Pfizer asks U.S. regulators to approve promising COVID pill By Matthew Perrone, Associated Press Pfizer is submitting its experimental pill for COVID-19 for U.S. authorization, setting the stage for a likely launch of the promising therapy in coming weeks. Continue reading
Nov 12 Biden picks former FDA chief Califf to again lead the agency By Matthew Perrone, Zeke Miller, Associated Press Califf served as FDA commissioner for the last 11 months of President Barack Obama’s second term. Continue reading
Nov 09 FDA to consider COVID-19 booster shots from Pfizer for all adults By Lauran Neergaard, Associated Press Pfizer is asking U.S. regulators to allow boosters of its COVID-19 vaccine for anyone 18 or older. Older Americans and other groups particularly vulnerable to the virus have had access to a third dose of the Pfizer and BioNTech vaccine… Continue reading
Nov 02 WATCH: CDC advisory panel endorse Pfizer COVID-19 vaccine for kids ages 5 to 11 By Lauran Neergaard, Mike Stobbe, Associated Press The Centers for Disease Control and Prevention advisory panel will have a discussion and vote Tuesday on the use of the Pfizer COVID-19 vaccine for children between the ages of five to 11. Continue reading
Oct 26 WATCH: FDA advisers endorse COVID-19 vaccines for kids ages 5 to 11 By Lauran Neergaard, Matthew Perrone, Associated Press The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as a panel of government advisers on Tuesday endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds. Continue reading
Oct 20 FDA approves mixing COVID vaccines By Matthew Perrone, Lauran Neergaard, Associated Press The Food and Drug Administration announcement marks a big step toward expanding the U.S. booster campaign, which began with extra doses of the Pfizer vaccine last month. Continue reading
Oct 14 WATCH: FDA advisory committee endorses Moderna COVID booster shot By Lauran Neergaard, Matthew Perrone, Associated Press The panel of advisers to the Food and Drug Administration voted unanimously to recommend a booster shot for seniors, adults with other health problems, jobs or living situations that put them at increased risk for COVID-19. Continue reading
Oct 12 FDA authorizes first e-cigarette, cites benefit for smokers By Matthew Perrone, Associated Press For the first time, U.S. health officials have authorized an electronic cigarette, saying the R.J. Reynolds vaping device can benefit adult smokers. Continue reading